4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001929354-23-000003
10% owner bought 25,000 shares at an average $2.95 ($73,874)
From the SEC's structured data for this filing
Trades in this filing
Caissa Capital Management ltd. · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-17 | Purchase : show line 1 in the form | +15,000 | $2.96 | $44,436 | 1,282,700 | I |
| 2023-04-18 | Purchase : show line 2 in the form | +10,000 | $2.94 | $29,438 | 1,292,700 | I |
| Open-market purchases · 25,000 sh · avg $2.95 · $73,874 | ||||||
Loading xslF345X04/primary_doc.xml…